4.5 Article

Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data

期刊

BMJ-BRITISH MEDICAL JOURNAL
卷 349, 期 -, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmj.g4164

关键词

-

资金

  1. UK Medical Research Council (MRC) population health scientist fellowship [G0802432]
  2. NWO [916.12.154]
  3. EUR Fellowship
  4. Mayo Foundation for Medical Education and Research
  5. Medical Research Council
  6. British Heart Foundation
  7. Economic and Social Research Council
  8. National Heart Lung and Blood Institute [NHLBI: HL36310, HL 114901]
  9. National Institute on Aging [AG13196]
  10. US, NIH
  11. Netherlands Heart Foundation [2001 D 032, 2014T001]
  12. James and Ester King Foundation
  13. Florida State Department of Health
  14. American Heart Association
  15. Myron and Jane Hanley Award in Stroke research
  16. Medical Research Council Professorship
  17. Swedish Heart-Lung Foundation [20041151]
  18. Swedish Research Council [2007-5942, 8691, 0593]
  19. NIH National Heart Lung and Blood Institute [HHSN268200900009C]
  20. MRC [G1000718]
  21. UCL MBPhD
  22. MH CZ - DRO (Institute for Clinical and Experimental Medicine - IKEM) [IN 00023001]
  23. UK Economic and Social Research Council (NCRM) [ES/I025561/2]
  24. British Heart Foundation [PG/2008/008]
  25. Medical Research Council [MC_UU_12019/1, MRC G0601653, G0000934]
  26. National Institute of Health Research University College London Hospitals Biomedical Research Centre
  27. National Institute on Alcohol Abuse and Alcoholism [NIAAA: AA021223-01]
  28. MD Scientist Fellowship in Genetic Medicine (Northwestern Memorial Foundation)
  29. National Research Service Award (NIH/NIDA) [F32DA024920]
  30. NIH [HL075451]
  31. BHF [RG/10/12/28456]
  32. UK Medical Research Council [MC_UU_12013/1, MC_UU_12013/5, 092731]
  33. National Institute on Minority Health and Health Disparities of the National Institutes of Health [P20MD006899]
  34. Wellcome Trust [092731, WT088806, WT087997MA]
  35. National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]
  36. National Human Genome Research Institute [U01HG004402]
  37. National Institutes of Health [HHSN268200625226C, UL1RR025005]
  38. NIH Roadmap for Medical Research
  39. British Heart Foundation (BHF) [PG/09/022, PG/07/131/24254, RG/08/013/25942, RG/98002, RG2008/014, RG/07/005/23633]
  40. UK Department of Health Policy Research Programme (England) [0090049]
  41. National Heart, Lung and Blood Institute
  42. NHLBI [HHSN268200960009C]
  43. National Heart, Lung, and Blood Institute/National Institutes of Health [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095]
  44. National Heart, Lung, and Blood Institute (NHLBI) [HL46380, HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, N01HC65226, HL080295]
  45. Herlev Hospital
  46. Copenhagen University Hospital
  47. Copenhagen County Research Fund
  48. Danish Medical Research Council
  49. National Institute on Aging (NIA) [AG023629]
  50. Cyprus Cardiovascular Disease Educational and Research Trust (CCDERT)
  51. Joint Cyprus Research Promotion Foundation, Ministry of Health
  52. Cyprus Heart Foundation [41/5PE]
  53. Research Promotion Foundation [PENEK 05/04, YGEIA 04/06]
  54. National Institute on Ageing (NIA) [AG1764406S1]
  55. European Union of the European Community [LSHM-CT-2006-037197]
  56. European Commission: Public Health and Consumer Protection Directorate
  57. Dutch Ministry of Public Health, Welfare and Sports
  58. Netherlands Cancer Registry
  59. LK Research Funds
  60. Dutch Prevention Funds
  61. Dutch Zorg Onderzoek Nederland
  62. World Cancer Research Fund (The Netherlands)
  63. 'Europe against Cancer' Programme of the European Commission (SANCO)
  64. Dutch Ministry of Public Health, Welfare and Sports (VWS)
  65. Netherlands Cancer Registry (NKR)
  66. Dutch Cancer Society
  67. ZonMW the Netherlands Organisation for Health Research and Development
  68. World Cancer Research Fund (WCRF) (The Netherlands)
  69. IOP Genomics grant from Agentschap NL [IGE05012]
  70. Cancer Research UK
  71. Federal Ministry of Science, Germany [01 EA 9401]
  72. European Union [SOC 95201408 05F02]
  73. German Cancer Aid [70-2488-Ha I]
  74. European Community [SOC 98200769 05F02]
  75. Federal Ministry of Education and Research [0312750B]
  76. German Research Federal Ministry (BMBF)
  77. Heisenberg-Professorship [SP716/1-1]
  78. German Research Foundation (DFG) [KFO192/1, 218/1]
  79. graduate school of the DFG [GK1208]
  80. Associazione Italiana per le Ricerche sul Cancro, Italy
  81. Compagnia di San Paolo, Turin, Italy
  82. Wellcome Trust 'Determinants of Cardiovascular Diseases in Eastern Europe: A multi-centre cohort study' [064947/Z/01/Z, 081081/Z/06/Z]
  83. MacArthur Foundation 'MacArthur Initiative on Social Upheaval and Health' [712058]
  84. National Institute on Ageing 'Health disparities and aging in societies in transition (the HAPIEE study)' [1R01 AG23522]
  85. Ministry of Health, Czech Republic [00023001]
  86. National Health and Medical Research Council (NHMRC) [279408, 379600, 403963, 513823, 634492]
  87. National Institute of Health, Bethesda
  88. M. D [HL35464, CA55075, CA87969, AA11181, HL34594]
  89. European Commission [QLG1-CT-2002-00896]
  90. Ministero della Salute Ricerca Corrente, Italy
  91. Swedish Heart-Lung Foundation
  92. Foundation for Strategic Research
  93. Stockholm County Council [562183]
  94. Academy of Finland [110413, 12926]
  95. Danish Centre for Evaluation and Health Technology Assessment
  96. Copenhagen County
  97. Danish Heart Foundation
  98. Danish Pharmaceutical Association
  99. Health Insurance Foundation
  100. Augustinus Foundation
  101. Ib Henriksens foundation
  102. Beckett Foundation
  103. Danish Diabetes Association [32]
  104. Health Insurance Foundation [2010 B 131]
  105. ISGS/SWISS: ISGS - National Institute of Neurological Disorders and Stroke (US) [R01 42733]
  106. SWISS - National Institute of Neurological Disorders and Stroke (US) [R01 NS39987]
  107. UK Wellcome Trust [078557]
  108. Swedish Medical Research Council
  109. Swedish Heart and Lung Foundation
  110. Medical Faculty of Lund University, Malmo University Hospital
  111. Albert Pahlsson Research Foundation
  112. Crafoord foundation
  113. Ernhold Lundstroms Research Foundation
  114. Region Skane
  115. Hulda and Conrad Mossfelt Foundation
  116. King Gustaf V and Queen Victoria Foundation
  117. Lennart Hanssons Memorial Fund
  118. Marianne and Marcus Wallenberg Foundation
  119. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development
  120. Juvenile Diabetes Research Foundation International (JDRF)
  121. MRC
  122. British Medical Research Council
  123. US National Institutes of Health [NHLBI 33014]
  124. Du Pont Pharma, Wilmington, Delaware
  125. Dutch Kidney Foundation [E033]
  126. Netherlands organisation for health research and development (ZonMw) [90.700.441]
  127. Dutch Inter University Cardiology Institute Netherlands (ICIN)
  128. EU FP7 Program [LSHM-CT-2007-037273]
  129. AstraZeneca
  130. Oxford BHF Centre of Research Excellence
  131. Wellcome Trust core award [090532/Z/09/Z]
  132. Swedish Research Council
  133. Knut and Alice Wallenberg Foundation
  134. Torsten and Ragnar Soderberg Foundation
  135. Strategic Cardiovascular Program of Karolinska Institutet
  136. Stockholm County Council
  137. Bristol-Myers Squibb
  138. Interuniversity Cardiology Institute of the Netherlands (ICIN)
  139. Netherlands Royal Academy of Arts and Sciences (KNAW)
  140. Netherlands Heart Foundation
  141. Center for Medical Systems Biology (CMSB)
  142. Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging) [050-060-810]
  143. Erasmus Medical Center
  144. Erasmus University Rotterdam
  145. Netherlands Organization for Scientific Research (NWO)
  146. Netherlands Organization for Health Research and Development (ZonMw)
  147. Research Institute for Diseases in the Elderly (RIDE)
  148. Ministry of Education, Culture and Science
  149. Ministry of Health Welfare and Sports
  150. European Commission
  151. Municipality of Rotterdam
  152. Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]
  153. Research Institute for Diseases in the Elderly [014-93-015, RIDE2]
  154. Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) [050-060-810]
  155. BBMRI-NL
  156. Dutch government (NWO) [184.021.007]
  157. Bayer Corporation
  158. Veni grant Organization for Scientific Research (NWO) [2001.064]
  159. Netherlands Heart Foundation (NHS)
  160. TI Pharma [T6-101]
  161. Netherlands Organisation for Health Research and Development (ZonMW)
  162. Dutch Health Care Insurance Board (CVZ)
  163. Royal Dutch Pharmacists Association (KNMP)
  164. Top Institute Pharma
  165. EU Innovative Medicines Initiative (IMI)
  166. EU 7th Framework Program (FP7)
  167. Dutch Medicines Evaluation Board
  168. Dutch Ministry of Health and industry (GlaxoSmithKline)
  169. Dutch Ministry of Health and industry (Pfizer)
  170. National Heart Lung and Blood Institute (NHLBI) [HL36310]
  171. National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]
  172. [R01HL087641]
  173. [R01HL59367]
  174. [R01HL086694]
  175. [U01 DK062418]
  176. ESRC [ES/I025561/3, ES/I025561/1, ES/F02679X/1, ES/J023299/1, ES/I025561/2] Funding Source: UKRI
  177. MRC [G1000718, MC_UU_12019/1, G0600580, G0802432, G0902037, G0701863, G0601647, G1001799, G0000934, G1000616, MC_UU_12013/5, G0902144, MC_UU_12013/1, MR/K013351/1, G0701830, MC_UU_12013/8, MC_UU_12015/1] Funding Source: UKRI
  178. British Heart Foundation [RG/08/013/25942, RG/07/008/23674, RG/10/12/28456, RG/13/16/30528, RG/08/008/25291, PG/13/66/30442] Funding Source: researchfish
  179. Cancer Research UK [14136] Funding Source: researchfish
  180. Economic and Social Research Council [ES/F02679X/1, ES/I025561/3, ES/I025561/2, ES/J023299/1, ES/I025561/1] Funding Source: researchfish
  181. Medical Research Council [G0401527, G1000616, MC_UU_12013/1, MC_UU_12013/8, G0601647, G8802774, G0701863, G0600580, G0000934, MC_U106179471, G1001799, MR/K013351/1, G0802432, G0902037, G0701830, MC_PC_15018, MR/K006584/1, G1000143, MC_UU_12015/1, G19/35, MC_UU_12013/5, G0100222, G1000718, MC_UU_12019/1] Funding Source: researchfish
  182. National Institute for Health Research [NF-SI-0512-10135, NF-SI-0512-10114] Funding Source: researchfish
  183. Novo Nordisk Fonden [NNF13OC0005339, NNF14OC0009819] Funding Source: researchfish

向作者/读者索取更多资源

Objective To use the rs1229984 variant in the alcohol dehydrogenase 1B gene (ADH1B) as an instrument to investigate the causal role of alcohol in cardiovascular disease. Design Mendelian randomisation meta-analysis of 56 epidemiological studies. Participants 261 991 individuals of European descent, including 20 259 coronary heart disease cases and 10 164 stroke events. Data were available on ADH1B rs1229984 variant, alcohol phenotypes, and cardiovascular biomarkers. Main outcome measures Odds ratio for coronary heart disease and stroke associated with the ADH1B variant in all individuals and by categories of alcohol consumption. Results Carriers of the A-allele of ADH1B rs1229984 consumed 17.2% fewer units of alcohol per week (95% confidence interval 15.6% to 18.9%), had a lower prevalence of binge drinking (odds ratio 0.78 (95% CI 0.73 to 0.84)), and had higher abstention (odds ratio 1.27 (1.21 to 1.34)) than non-carriers. Rs1229984 A-allele carriers had lower systolic blood pressure (-0.88 (-1.19 to -0.56) mm Hg), interleukin-6 levels (-5.2% (-7.8 to -2.4%)), waist circumference (-0.3 (-0.6 to -0.1) cm), and body mass index (-0.17 (-0.24 to -0.10) kg/m(2)). Rs1229984 A-allele carriers had lower odds of coronary heart disease (odds ratio 0.90 (0.84 to 0.96)). The protective association of the ADH1B rs1229984 A-allele variant remained the same across all categories of alcohol consumption (P= 0.83 for heterogeneity). Although no association of rs1229984 was identified with the combined subtypes of stroke, carriers of the A-allele had lower odds of ischaemic stroke (odds ratio 0.83 (0.72 to 0.95)). Conclusions Individuals with a genetic variant associated with non-drinking and lower alcohol consumption had a more favourable cardiovascular profile and a reduced risk of coronary heart disease than those without the genetic variant. This suggests that reduction of alcohol consumption, even for light to moderate drinkers, is beneficial for cardiovascular health.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据